1. "Hematologic Malignancies, Division of"
Formats
  1. Meeting Abstract (6210)
  2. Journal Article (5696)
  3. Review (405)
  4. Book Section (186)
  5. Editorial (186)
  6. Research Letter (169)
  7. Guidelines (86)
  8. Conference Paper (65)
  9. Correspondence (58)
  10. Miscellaneous (17)
  11. Book Whole (9)
Groups
  1. Hematologic Malignancies, Division of (13087)
  2. Department of Medicine (13003)
  3. Center for Hematologic Malignancies (10394)
  4. GSK Faculty (4421)
  5. Adult Leukemia (3582)
  6. Bone Marrow Transplant (2776)

More Groups

People
  1. Sergio Giralt (1050)
  2. Miguel-Angel Perales (913)
  3. Ross Levine (774)
  4. Andrew Zelenetz (767)
  5. Martin Tallman (649)
  6. Steven Horwitz (645)

More People

Years
  1. 2025 (203)
  2. 2024 (670)
  3. 2023 (1038)
  4. 2022 (964)
  5. 2021 (875)
  6. 2020 (936)

More Years

Publications
  1. Blood (3371)
  2. Journal of Clinical Oncology (1214)
  3. Biology of Blood and Marrow Transplantation (596)
  4. Clinical Lymphoma, Myeloma and Leukemia (328)
  5. Haematologica (289)
  6. Bone Marrow Transplantation (238)

More Publications

Publishers
  1. American Society of Hematology (3638)
  2. Elsevier Inc. (1609)
  3. American Society of Clinical Oncology (1266)
  4. Nature Publishing Group (994)
  5. American Association for Cancer Research (637)
  6. Wiley Blackwell (430)

More Publishers

Results (13087)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Genetic targeting of ERK1/ERK2 kinases impairs the fitness of the myeloproliferative neoplasm clone
    Meeting Abstract

    Stivala, S.; Brkic, S.; Dirnhofer, S.; Passweg, J. R.; Tsakiris, D. A.; Neel, B. G.; Levine, R. L.; Meyer, S. C.
    Swiss Medical Weekly (2019)

    Fulltext@MSK | Save
  • Resistance to type II JAK2 inhibition in MPN is dependent on targetable MAPK activation and is reversible
    Meeting Abstract

    Szybinski, J.; Codilupi, T.; Ghosh, N.; Passweg, J.; Tsakiris, D.; Radimerski, T.; Levine, R. L.; Meyer, S. C.
    Swiss Medical Weekly (2019)

    Fulltext@MSK | Save
  • Dual JAK2 and ERK1/2 kinase inhibition as a potent corrective approach in myeloproliferative neoplasms
    Meeting Abstract

    Brkic, S.; Stivala, S.; Jungius, S.; Santopolo, A.; Passweg, J. R.; Tsakiris, D.; Radimerski, T.; Munck, J.; Levine, R. L.; Meyer, S. C.
    Swiss Medical Weekly (2019)

    Fulltext@MSK | Save
  • Resource utilization within 30 days of car T cells for hematologic malignancies
    Meeting Abstract

    Shah, G.; Park, J.; Sauter, C.; Duck, E.; Halton, E.; Batlevi, C.; Palomba, M. L.; Younes, A.; Geyer, M.; Smith, E.; more...
    Value in Health (2019)

    Fulltext@MSK | Save
  • Preclinical development and first-in-human imaging of 89Zr-daratumumab for CD38 targeted imaging of myeloma
    Meeting Abstract

    Ulaner, G.; Sobol, N.; O'Donoghue, J.; Burnazi, E.; Staton, K.; Weber, W.; Lyashchenko, S.; Lewis, J.; Landgren, C. O.
    Journal of Nuclear Medicine (2019)

    Fulltext@MSK | Save
  • Efficacy of mogamulizumab in patients with previously treated cutaneous T-cell lymphoma: Post hoc analysis from the phase III MAVORIC study
    Meeting Abstract

    Scarisbrick, J.; Zinzani, P. L.; Horwitz, S.; Kim, Y. H.; Moskowitz, A. J.; Porcu, P.; Leoni, M.; Dwyer, K.; Sun, W.; Nikonova, E.; more...
    British Journal of Dermatology (2019)

    Fulltext@MSK | Save
  • PD-1 blockade with pembrolizumab for classical Hodgkin lymphoma after autologous stem cell transplantation
    Journal Article

    Armand, P.; Chen, Y. B.; Redd, R. A.; Joyce, R. M.; Bsat, J.; Jeter, E.; Merryman, R. W.; Coleman, K. C.; Dahi, P. B.; Nieto, Y.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Guillain BarreĢ syndrome heralding the diagnosis of angioimmunoblastic T-cell lymphoma
    Journal Article

    Pathak, P.; Perimbeti, S.; Ames, A.; Moskowitz, A. J.
    Leukemia and Lymphoma (2019)

    Fulltext@MSK | Save
  • Combined use of tofacitinib (pan-JAK inhibitor) and ruxolitinib (a JAK1/2 inhibitor) for refractory T-cell prolymphocytic leukemia (T-PLL) with a JAK3 mutation
    Journal Article

    Gomez-Arteaga, A.; Margolskee, E.; Wei, M. T.; van Besien, K.; Inghirami, G.; Horwitz, S.
    Leukemia and Lymphoma (2019)

    Fulltext@MSK | Save
  • Sequentially inducible mouse models reveal that Npm1 mutation causes malignant transformation of Dnmt3a-mutant clonal hematopoiesis
    Journal Article

    Loberg, M. A.; Bell, R. K.; Goodwin, L. O.; Eudy, E.; Miles, L. A.; SanMiguel, J. M.; Young, K.; Bergstrom, D. E.; Levine, R. L.; Schneider, R. K.; more...
    Leukemia (2019)

    Fulltext@MSK | Save